Dr. Vasily Rozenbaum, MD

Dr. Rozenbaum practices at Baptist Primary Care Inc in Jacksonville, Florida.

Dr. Rozenbaum's NPI, 1245727973, was assigned on April 18, 2018. Dr. Rozenbaum graduated from St. George's University School of Medicine in 2018. Dr. Rozenbaum holds Florida license ME155472.

Dr. Rozenbaum's primary practice is Baptist Primary Care Inc, at 524 Skymarks Dr, Jacksonville, FL 32218 in Duval County. The practice phone is (904) 376-3707.

Dr. Rozenbaum's primary practice is Baptist Primary Care Inc in Jacksonville, Florida. Dr. Rozenbaum is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Baptist Primary Care. Dmand AI also links Dr. Rozenbaum to 3 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rozenbaum practices, 7 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Rozenbaum's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Rozenbaum is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Rozenbaum's licenses on file in 2 states: Florida and California.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, alzheimer's disease, aneurysm, ankle or foot injury, arterial blot clot /embolism and arthritis among the conditions Dr. Rozenbaum treats.

CMS data shows 3,206 Medicare services from Dr. Rozenbaum across 23 procedure codes in 2024, for 357 Medicare patients. Medicare paid $168,689 for them. Every service was in an office.

CMS counts 357 Medicare patients who saw Dr. Rozenbaum in 2024. The largest group is 75 to 84, with 152 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rozenbaum's median patient age at 71, with 45% women.

In 2024, Dr. Rozenbaum wrote 5,592 Medicare Part D claims for 489 patients. 83% of them were for generic drugs. CMS names the drug for 4,918 of them, across 99 drugs with 11 or more claims each, at $572,501 in total drug cost. In 2023, CMS named 2,198 claims across 65 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Rozenbaum for performance year 2024, reported through an alternative payment model (APM). Dr. Rozenbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rozenbaum as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Rozenbaum. Dr. Rozenbaum's most frequent co-authors are Amrit Singh Ahluwalia, MD and Bernadette Pendergraph, MD.

CMS Open Payments shows 214 general payments to Dr. Rozenbaum from 42 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,016.

Dr. Rozenbaum graduated from St. George's University School of Medicine in 2018.

Dr. Rozenbaum is in network with 18 carriers, including Aetna, HCSC and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.